Information Collecting from CDx Manufacturers
On June 3, 2020, CMDE released a notice about collecting information from domestic and foreign manufacturers who have approved products or intend to be engaged in the production of CDx (Companion Diagnostics). All the information is collected for compiling the Technical Guidelines for the Clinical Trials of CDx Simultaneously Developing with Anti-tumor Drugs, which will guide the clinical trial conduction for the CDx registration application.
